Complete Filing Data
Edgewise Therapeutics, Inc. reported Stockholders Equity of $522.26 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Edgewise Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$167.8M | -$133.8M | -$100.2M | -$67.6M | -$42.8M | -$17.1M |
| Other Comprehensive Income Loss Net Of Tax | $257.0K | $321.0K | $1.5M | -$841.0K | -$514.0K | |
| Research And Development Expense | $151.4M | $127.0M | $90.9M | $54.0M | $32.2M | $15.0M |
| Other Nonoperating Income | $23.6M | $25.0M | $14.2M | $4.0M | $402.0K | $69.0K |
| Operating Income Loss | -$191.4M | -$158.8M | -$114.4M | -$71.7M | -$43.2M | -$17.2M |
| Operating Expenses | $191.4M | $158.8M | $114.4M | $71.7M | $43.2M | $17.2M |
| General And Administrative Expense | $40.0M | $31.9M | $23.5M | $17.6M | $11.0M | $2.2M |
| Comprehensive Income Net Of Tax | -$167.5M | -$133.5M | -$98.7M | -$68.5M | -$43.3M | -$17.1M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $257.0K | $321.0K | $1.5M | -$841.0K | -$514.0K | |
| Income Loss From Continuing Operations Per Diluted Share | -$1.45 | -$1.57 | -$1.26 | -$1.14 | -$23.17 | |
| Income Loss From Continuing Operations Per Basic Share | -$1.45 | -$1.57 | -$1.26 | -$1.14 | -$23.17 | |
| Income Loss From Continuing Operations Per Basic And Diluted Share |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$40.7M | -$36.1M | -$40.8M | -$34.1M | -$31.5M | -$28.5M | -$25.7M | -$21.5M | -$22.8M | -$17.5M | -$16.1M | -$14.7M | -$12.9M | -$10.4M | -$6.8M | -$3.6M | -$4.0M | -$3.2M |
| Other Comprehensive Income Loss Net Of Tax | $497.0K | -$197.0K | -$19.0K | $2.1M | -$193.0K | -$960.0K | $123.0K | -$296.0K | $1.1M | $157.0K | -$404.0K | -$1.4M | $9.0K | $21.0K | -$54.0K | |||
| Research And Development Expense | $37.5M | $33.6M | $36.8M | $32.2M | $30.7M | $27.7M | $23.8M | $19.6M | $19.9M | $13.9M | $12.4M | $11.1M | $9.9M | $7.9M | $5.4M | $3.2M | $3.6M | $3.0M |
| Other Nonoperating Income | $6.2M | $6.5M | $5.2M | $6.3M | $6.6M | $6.2M | $3.7M | $3.9M | $2.9M | $764.0K | $424.0K | $166.0K | $127.0K | $107.0K | $42.0K | $1.0K | $3.0K | $63.0K |
| Operating Income Loss | -$46.9M | -$42.6M | -$46.0M | -$40.4M | -$38.1M | -$34.8M | -$29.5M | -$25.3M | -$25.7M | -$18.3M | -$16.5M | -$14.8M | -$13.1M | -$10.5M | -$6.9M | -$3.6M | -$4.0M | -$3.2M |
| Operating Expenses | $46.9M | $42.6M | $46.0M | $40.4M | $38.1M | $34.8M | $29.5M | $25.3M | $25.7M | $18.3M | $16.5M | $14.8M | $13.1M | $10.5M | $6.9M | $3.6M | $4.0M | $3.2M |
| General And Administrative Expense | $9.4M | $9.1M | $9.2M | $8.2M | $7.4M | $7.1M | $5.7M | $5.8M | $5.8M | $4.4M | $4.1M | $3.7M | $3.2M | $2.6M | $1.5M | $405.0K | $318.0K | $281.0K |
| Comprehensive Income Net Of Tax | -$40.2M | -$36.3M | -$40.8M | -$32.0M | -$31.7M | -$29.5M | -$25.6M | -$21.8M | -$21.7M | -$17.3M | -$16.5M | -$16.1M | -$12.9M | -$10.3M | -$6.9M | -$3.6M | -$4.0M | -$3.2M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $497.0K | -$197.0K | -$19.0K | $2.1M | -$193.0K | -$960.0K | $123.0K | -$296.0K | $1.1M | $157.0K | -$404.0K | -$1.4M | $9.0K | $21.0K | -$54.0K | |||
| Income Loss From Continuing Operations Per Diluted Share | -$0.39 | -$0.34 | -$0.43 | -$0.36 | -$0.34 | -$0.33 | -$0.41 | -$0.34 | -$0.36 | -$0.34 | -$0.32 | -$0.30 | -$0.26 | -$0.21 | -$4.37 | |||
| Income Loss From Continuing Operations Per Basic Share | -$0.39 | -$0.34 | -$0.43 | -$0.36 | -$0.34 | -$0.33 | -$0.41 | -$0.34 | -$0.36 | -$0.34 | -$0.32 | -$0.30 | -$0.26 | -$0.21 | -$4.37 | |||
| Income Loss From Continuing Operations Per Basic And Diluted Share | -$0.26 | -$0.21 | -$4.37 | -$3.68 | -$7.43 | -$7.57 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $522.3M | $459.2M | $318.8M | $346.7M | $274.4M | -$33.4M | -$16.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $61.1M | $41.7M | $86.1M | $22.0M | $15.6M | $104.9M | $23.7M |
| Cash And Cash Equivalents At Carrying Value | $61.1M | $41.7M | $86.1M | $22.0M | $15.6M | $104.9M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $19.5M | -$44.4M | $64.1M | $6.4M | -$89.4M | $81.3M | |
| Retained Earnings Accumulated Deficit | -$546.4M | -$378.6M | -$244.8M | -$144.6M | -$77.0M | -$34.1M | |
| Property Plant And Equipment Net | $7.8M | $9.5M | $10.4M | $8.5M | $912.0K | $516.0K | |
| Prepaid Expense And Other Assets Current | $13.3M | $5.3M | $8.6M | $5.1M | $3.0M | $551.0K | |
| Marketable Securities | $469.0M | $428.5M | $232.3M | $330.0M | $265.2M | $24.2M | |
| Liabilities Current | $27.4M | $23.9M | $16.8M | $16.6M | $10.5M | $4.3M | |
| Liabilities And Stockholders Equity | $552.6M | $486.8M | $340.0M | $367.1M | $285.2M | $131.1M | |
| Employee Related Liabilities Current | $12.4M | $10.1M | $5.7M | $4.0M | $2.8M | $1.2M | |
| Assets Current | $543.4M | $475.5M | $327.0M | $357.0M | $283.8M | $129.6M | |
| Assets | $552.6M | $486.8M | $340.0M | $367.1M | $285.2M | $131.1M | |
| Accrued Liabilities Current | $7.9M | $7.2M | $6.1M | $5.8M | $3.9M | $1.6M | |
| Accounts Payable Current | $6.0M | $5.6M | $4.0M | $6.1M | $3.8M | $1.6M | |
| Liabilities | $30.3M | $27.6M | $21.2M | $20.4M | $10.9M | $4.3M | |
| Common Stock Value | $10.0K | $9.0K | $7.0K | $6.0K | $5.0K | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $677.0K | $420.0K | $99.0K | -$1.4M | -$514.0K | ||
| Other Assets Noncurrent | $262.0K | $348.0K | $251.0K | $548.0K | $975.0K | ||
| Finance Lease Right Of Use Asset Amortization | $182.0K | $221.0K | $181.0K | $170.0K | |||
| Accretion Amortization Of Discounts And Premiums Investments | $7.7M | $12.5M | $9.5M | $543.0K | |||
| Operating Lease Right Of Use Asset | $1.4M | $1.6M | $2.2M | $1.3M | |||
| Operating Lease Liability Noncurrent | $3.0M | $3.7M | $4.4M | $3.8M | |||
| Operating Lease Liability Current | $1.0M | $996.0K | $980.0K | $608.0K | |||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $1.1M | $1.5M | |||||
| Property Plant And Equipment Gross | $946.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $558.6M | $589.1M | $429.7M | $488.9M | $510.5M | $534.9M | $290.4M | $311.5M | $328.8M | $361.4M | $246.4M | $260.4M | $285.4M | $296.8M | $306.4M | -$27.3M | -$23.8M | -$20.0M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $46.0M | $43.4M | $49.9M | $44.8M | $43.5M | $30.3M | $33.0M | $31.8M | $48.2M | $109.7M | $18.3M | $34.5M | $10.6M | $50.4M | $221.0M | |||||
| Cash And Cash Equivalents At Carrying Value | $46.0M | $43.4M | $49.9M | $44.8M | $43.5M | $30.3M | $33.0M | $31.8M | $48.2M | $109.7M | $18.3M | $34.5M | $10.6M | $50.4M | $221.0M | $38.7M | $16.9M | $20.9M | $23.7M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $8.3M | -$55.8M | $26.2M | $18.9M | $116.1M | -$2.7M | ||||||||||||||
| Retained Earnings Accumulated Deficit | -$496.2M | -$455.5M | -$419.4M | -$338.9M | -$304.8M | -$273.3M | -$214.6M | -$188.9M | -$167.4M | -$125.2M | -$107.7M | -$91.6M | -$64.3M | -$51.3M | -$41.0M | |||||
| Property Plant And Equipment Net | $8.1M | $8.6M | $9.0M | $10.0M | $9.9M | $10.2M | $10.7M | $10.9M | $10.4M | $5.4M | $2.0M | $1.4M | $911.0K | $524.0K | $499.0K | |||||
| Prepaid Expense And Other Assets Current | $10.6M | $9.3M | $6.8M | $6.9M | $7.7M | $8.7M | $8.2M | $7.1M | $5.4M | $5.3M | $4.9M | $2.8M | $2.8M | $3.8M | $674.0K | |||||
| Marketable Securities | $517.3M | $550.6M | $386.5M | $447.7M | $468.3M | $502.5M | $256.7M | $278.1M | $279.7M | $255.1M | $230.1M | $231.4M | $279.9M | $248.7M | $88.8M | |||||
| Liabilities Current | $21.6M | $20.9M | $21.1M | $19.0M | $17.2M | $14.6M | $16.3M | $14.4M | $12.7M | $13.3M | $9.2M | $10.0M | $8.8M | $6.7M | $4.9M | |||||
| Liabilities And Stockholders Equity | $583.5M | $613.3M | $454.4M | $511.3M | $531.6M | $553.8M | $311.4M | $330.6M | $346.4M | $377.2M | $257.4M | $272.7M | $294.4M | $303.5M | $311.2M | |||||
| Employee Related Liabilities Current | $8.0M | $5.6M | $4.0M | $6.2M | $4.2M | $2.9M | $4.4M | $3.1M | $2.1M | $2.7M | $2.0M | $1.3M | $2.0M | $1.4M | $672.0K | |||||
| Assets Current | $573.9M | $603.3M | $443.2M | $499.4M | $519.4M | $541.4M | $297.9M | $317.0M | $333.4M | $370.1M | $253.3M | $268.6M | $293.2M | $303.0M | $310.5M | |||||
| Assets | $583.5M | $613.3M | $454.4M | $511.3M | $531.6M | $553.8M | $311.4M | $330.6M | $346.4M | $377.2M | $257.4M | $272.7M | $294.4M | $303.5M | $311.2M | |||||
| Accrued Liabilities Current | $6.5M | $5.9M | $7.4M | $6.1M | $5.1M | $6.0M | $5.7M | $6.6M | $6.0M | $4.6M | $4.3M | $3.3M | $4.4M | $2.6M | $2.6M | |||||
| Accounts Payable Current | $6.2M | $8.3M | $8.8M | $5.6M | $6.8M | $4.7M | $5.3M | $3.8M | $3.9M | $5.8M | $2.8M | $5.3M | $2.3M | $2.8M | $1.6M | |||||
| Liabilities | $24.8M | $24.3M | $24.7M | $22.4M | $21.2M | $18.9M | $20.9M | $19.2M | $17.6M | $15.7M | $11.0M | $12.4M | $9.0M | |||||||
| Common Stock Value | $10.0K | $10.0K | $9.0K | $9.0K | $9.0K | $9.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $701.0K | $204.0K | $401.0K | $1.1M | -$1.1M | -$861.0K | -$424.0K | -$547.0K | -$251.0K | -$2.2M | -$2.3M | -$1.9M | -$24.0K | -$33.0K | -$54.0K | |||||
| Other Assets Noncurrent | $695.0K | $262.0K | $262.0K | $467.0K | $419.0K | $251.0K | $264.0K | $447.0K | $559.0K | $295.0K | $201.0K | |||||||||
| Finance Lease Right Of Use Asset Amortization | $41.0K | $52.0K | $46.0K | $44.0K | ||||||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $1.9M | $3.2M | $2.1M | -$670.0K | ||||||||||||||||
| Operating Lease Right Of Use Asset | $1.4M | $1.5M | $1.5M | $1.6M | $2.0M | $2.2M | $2.3M | $2.4M | $2.4M | $1.3M | $1.6M | $2.1M | ||||||||
| Operating Lease Liability Noncurrent | $3.2M | $3.4M | $3.6M | $3.4M | $4.0M | $4.3M | $4.6M | $4.8M | $4.8M | $2.4M | $1.6M | $2.2M | ||||||||
| Operating Lease Liability Current | $1.0M | $1.0M | $1.0M | $992.0K | $988.0K | $984.0K | $931.0K | $872.0K | $797.0K | $209.0K | $104.0K | |||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $1.1M | $2.2M | ||||||||||||||||||
| Property Plant And Equipment Gross | $2.9M | $2.2M | $1.6M | $1.5M | $1.1M | $1.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $34.8M | $24.7M | $17.6M | $10.9M | $4.4M | $354.0K |
| Share Based Compensation | $34.8M | $24.7M | $17.6M | $10.9M | $4.4M | $354.0K |
| Net Cash Provided By Used In Operating Activities | -$143.8M | -$109.0M | -$91.9M | -$52.6M | -$33.5M | -$14.6M |
| Net Cash Provided By Used In Investing Activities | -$32.8M | -$184.7M | $102.9M | -$70.6M | -$242.2M | -$24.4M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $8.0M | -$3.3M | $3.6M | $1.5M | $2.4M | $417.0K |
| Increase Decrease In Other Accrued Liabilities | $691.0K | $1.2M | $526.0K | $1.3M | $2.7M | $1.0M |
| Increase Decrease In Employee Related Liabilities | $2.4M | $4.4M | $1.7M | $1.2M | $1.6M | $842.0K |
| Increase Decrease In Accounts Payable | $272.0K | $1.7M | -$92.0K | $47.0K | $2.7M | $521.0K |
| Proceeds From Stock Options Exercised | $7.8M | $9.5M | $117.0K | $405.0K | $112.0K | $202.0K |
| Net Cash Provided By Used In Financing Activities | $196.1M | $249.3M | $53.2M | $129.6M | $186.4M | $120.3M |
| Payments To Acquire Marketable Securities | $527.2M | $477.1M | $255.9M | $292.4M | $288.2M | $24.2M |
| Payments To Acquire Property Plant And Equipment | $256.0K | $1.3M | $5.7M | $5.5M | $668.0K | $203.0K |
| Proceeds From Sale And Maturity Of Marketable Securities | $277.9M | $344.4M | $196.8M | $43.2M | ||
| Increase Decrease In Operating Lease Liability | -$748.0K | -$220.0K | -$104.0K | $2.9M | ||
| Proceeds From Issuance Of Common Stock | $187.4M | $239.1M | $52.6M | $129.2M | ||
| Proceeds From Sale Of Marketable Securities | $15.8M | $20.1M | $30.6M | $3.4M | ||
| Proceeds From Stock Plans | $923.0K | $888.0K | $596.0K | $320.0K | $248.0K | |
| Payments Of Debt Issuance Costs | $262.0K | $165.0K | $251.0K | |||
| Stock Issued During Period Value Share Based Compensation | $7.8M | $9.5M | $117.0K | |||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | $430.0K | |||||
| Payments Of Stock Issuance Costs | $500.0K | $124.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $8.1M | $7.7M | $9.1M | $6.9M | $5.2M | $4.9M | $4.6M | $4.0M | $3.8M | $3.2M | $2.0M | $2.0M | $1.5M | $687.0K | $296.0K | $70.0K | $49.0K | $45.0K | |
| Share Based Compensation | $9.1M | $4.9M | $3.8M | $2.0M | $296.0K | $45.0K | |||||||||||||
| Net Cash Provided By Used In Operating Activities | -$37.9M | -$28.6M | -$22.8M | -$12.6M | -$6.1M | -$2.7M | |||||||||||||
| Net Cash Provided By Used In Investing Activities | $43.9M | -$268.3M | $49.0M | $31.4M | -$64.8M | -$9.0K | |||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.5M | $63.0K | $359.0K | -$398.0K | $66.0K | $41.0K | |||||||||||||
| Increase Decrease In Other Accrued Liabilities | $122.0K | -$102.0K | $370.0K | -$846.0K | $1.0M | $22.0K | |||||||||||||
| Increase Decrease In Employee Related Liabilities | -$6.1M | -$2.8M | -$2.0M | -$1.5M | -$503.0K | -$78.0K | |||||||||||||
| Increase Decrease In Accounts Payable | $2.9M | $780.0K | -$160.0K | $1.2M | -$63.0K | $458.0K | |||||||||||||
| Proceeds From Stock Options Exercised | $2.3M | $1.9M | $21.0K | $73.0K | $23.0K | ||||||||||||||
| Net Cash Provided By Used In Financing Activities | $2.2M | $241.1M | $21.0K | $73.0K | $187.0M | ||||||||||||||
| Payments To Acquire Marketable Securities | $122.2M | $327.6M | $17.0M | $14.0M | $64.7M | ||||||||||||||
| Payments To Acquire Property Plant And Equipment | $297.0K | $4.4M | $369.0K | $62.0K | $9.0K | ||||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $151.1M | $58.7M | $69.8M | $36.9M | |||||||||||||||
| Increase Decrease In Operating Lease Liability | -$179.0K | -$164.0K | $116.0K | $24.0K | |||||||||||||||
| Proceeds From Issuance Of Common Stock | $239.1M | ||||||||||||||||||
| Proceeds From Sale Of Marketable Securities | $15.0M | $885.0K | $607.0K | $8.8M | |||||||||||||||
| Proceeds From Stock Plans | |||||||||||||||||||
| Payments Of Debt Issuance Costs | $38.0K | ||||||||||||||||||
| Stock Issued During Period Value Share Based Compensation | $1.7M | $233.0K | $1.6M | $31.0K | |||||||||||||||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | $882.0K | $785.0K | $702.0K | $624.0K | $560.0K | $509.0K | |||||||||||||
| Payments Of Stock Issuance Costs | $124.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 102.9M | 92.4M | 63.7M | 53.6M | 37.5M | 739.0K |
| Weighted Average Number Of Diluted Shares Outstanding | 102.9M | 92.4M | 63.7M | 53.6M | 37.5M | 739.0K |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 106.2M | 94.8M | 70.5M | 63.3M | 49.5M | 1.0M |
| Common Stock Shares Issued | 106.2M | 94.8M | 70.5M | 63.3M | 49.5M | 1.0M |
| Common Stock Shares Authorized | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 88.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | ||||||
| Earnings Per Share Diluted | $-1.63 | $-1.45 | $-1.57 | |||
| Earnings Per Share Basic | $-1.63 | $-1.45 | $-1.57 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 105.5M | 104.9M | 95.1M | 93.8M | 93.5M | 87.6M | 63.5M | 63.4M | 63.3M | 51.8M | 49.6M | 49.5M | 49.3M | 49.3M | 1.6M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 105.5M | 104.9M | 95.1M | 93.8M | 93.5M | 87.6M | 63.5M | 63.4M | 63.3M | 51.8M | 49.6M | 49.5M | 49.3M | 49.3M | 1.6M | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 105.8M | 105.3M | 95.2M | 94.4M | 93.6M | 93.3M | 63.5M | 63.5M | 63.3M | 63.2M | 49.8M | 49.6M | 49.3M | 49.3M | 49.3M | |||
| Common Stock Shares Issued | 105.8M | 105.3M | 95.2M | 94.4M | 93.6M | 93.3M | 63.5M | 63.5M | 63.3M | 63.2M | 49.8M | 49.6M | 49.3M | 49.3M | 49.3M | |||
| Common Stock Shares Authorized | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 49.3M | 49.3M | 1.6M | 989.2K | 532.4K | 420.5K | ||||||||||||
| Earnings Per Share Diluted | ||||||||||||||||||
| Earnings Per Share Basic |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Interest Income Other | $23.6M | $25.0M | $14.2M | $4.0M | $402.0K | $69.0K |
| Depreciation | $2.1M | $2.1M | $1.6M | $368.0K | $272.0K | $185.0K |
| Stock Issued During Period Value Stock Options Exercised | $117.0K | $405.0K | $116.0K | $202.0K | ||
| Additional Paid In Capital | $1.07B | $837.4M | $563.5M | $492.7M | $351.9M | $727.0K |
| Capital Expenditures Incurred But Not Yet Paid | $199.0K | $44.0K | $227.0K | $2.5M | ||
| Stock Issued During Period Value New Issues | $187.1M | $238.8M | $52.6M | $129.2M | $186.1M | |
| Stock Issued During Period Value Employee Stock Purchase Plan | $923.0K | $888.0K | $596.0K | $320.0K | $248.0K | |
| Stock Issued During Period Shares New Issues | 9.9M | 13.4M | ||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $160.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income Other | $6.2M | $6.5M | $5.2M | $6.3M | $6.6M | $6.2M | $3.7M | $3.9M | $2.9M | $764.0K | $424.0K | $166.0K | $127.0K | $107.0K | $42.0K | $1.0K | $3.0K | $63.0K |
| Depreciation | $500.0K | $500.0K | $513.0K | $500.0K | $500.0K | $473.0K | $400.0K | $400.0K | $195.0K | $100.0K | $100.0K | $83.0K | $100.0K | $51.0K | $79.0K | $49.0K | $46.0K | $40.0K |
| Stock Issued During Period Value Stock Options Exercised | $2.3M | $3.5M | $1.9M | $3.0K | $21.0K | $52.0K | $255.0K | $73.0K | $37.0K | $5.0K | $25.0K | $67.0K | $120.0K | $15.0K | ||||
| Additional Paid In Capital | $1.05B | $1.04B | $848.7M | $826.7M | $816.3M | $809.1M | $505.5M | $500.9M | $496.5M | $488.8M | $356.4M | $353.9M | $349.7M | $348.1M | $347.4M | |||
| Capital Expenditures Incurred But Not Yet Paid | $144.0K | $200.0K | $309.0K | |||||||||||||||
| Stock Issued During Period Value New Issues | $187.1M | $238.8M | $129.2M | $186.1M | ||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $597.0K | $422.0K | $338.0K | $178.0K | ||||||||||||||
| Stock Issued During Period Shares New Issues | 21.8M | |||||||||||||||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $160.2M |
Most recent annual filing with the SEC: February 26, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.